Meritage Homes
MTH
KB Home
KBH
D.R. Horton
DHI
4
Adobe
ADBE
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
NTRB Nutriband
- 6.880
- +1.200+21.13%
Close Apr 30 16:00 ET
- 7.100
- +0.220+3.20%
Post 20:01 ET
76.74MMarket Cap-6.95P/E (TTM)
8.110High6.450Low615.36KVolume7.100Open5.680Pre Close4.32MTurnover11.94%Turnover RatioLossP/E (Static)11.15MShares11.78052wk High11.94P/B35.47MFloat Cap3.35052wk Low--Dividend TTM5.16MShs Float11.780Historical High--Div YieldTTM29.23%Amplitude1.530Historical Low7.026Avg Price1Lot Size
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Nutriband Stock Forum
Revolutionary Opioid Safety Tech: Nutriband Secures 46-Country Patent Protection
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
Friday, 11th April at 7:00 am
ORLANDO, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB)(NASDAQ: NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has received notification that its patent has been granted in Macao for its patent entitled, "Abuse and Misuse Deterrent Transdermal Systems," whi...
Can This New Trademark Help Nutriband Capture a $200M Drug Delivery Market?
Nutriband Says It Received Certificate Of Registration For Trademark Covering Pharmaceutical And Product Research And Development
Revolutionary Abuse-Deterrent Fentanyl Patch Development: $200M Market Potential
Game-Changing Patent Win: Nutriband's Abuse-Proof Fentanyl Patch Could Hit $200M in Sales
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
Friday, 7th February at 8:45 am
ORLANDO, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB)(NASDAQ: NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) on February 3, 2025 for ...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow...
No comment yet